Accelerated ART Initiation for PWHIV Who Are Out of Care

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 29, 2024

Primary Completion Date

May 1, 2026

Study Completion Date

November 1, 2026

Conditions
HIV InfectionsARTNoncompliance, Patient
Interventions
OTHER

The Accelerate model of care

"Contact is established by the study team~The patient is provided with a telehealth appointment with an HIV care provider within 24 business hours of contact~At the time of enrollment/initial clinic visit, patients who meet the inclusion and exclusion criteria will be enrolled in the study~The HIV care provider will prescribe B/F/TAF to their pharmacy of choice.~B/F/TAF is dispensed by the designated study pharmacist and mailed to the patient as a free 30-day starter pack to allow time for benefits verification.~A telephone follow-up call by the study team will be conducted within 2 - 4 weeks from the initial clinical visit to assess any adverse events, tolerability, and adherence.~Hand-off to HIV clinic to establish care within 4 weeks. Lab results will be drawn during clinic per HIV care provider which might include CBC, CMP, HIV-1 RNA, CD4, and genotype resistance testing when clinically indicated by the HIV care provider."

DRUG

bictegravir/emtricitabine/tenofovir alafenamide 50/200/25 mg

Same as above, it is the same intervetion

Trial Locations (4)

63111

RECRUITING

NOVUS Health, St Louis

64124

RECRUITING

KC Care Health Center, Kansas City

65212

RECRUITING

University of Missouri-Columbia, Columbia

65804

RECRUITING

AIDS Project of the Ozarks, Springfield

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

University of Missouri-Columbia

OTHER